PKM2はヒストンH3をリン酸化し,遺伝子転写と腫瘍発生を促進する
Weiwei Yang1, Yan Xia, David Hawke
1Brain Tumor Center and Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Cell
|August 21, 2012
まとめ
腫瘍タンパク質PKM2はヒストンH3を直接修正し,遺伝子転写と脳腫瘍の成長に影響を与えます. このタンパク質キナーゼの活動は,表遺伝的調節に不可欠であり,潜在的な治療標的を提供します.
科学分野:
- 分子生物学は分子生物学である.
- がん研究 がん研究
- エピジェネティクス エピジェネティクス
背景:
- ピル酸塩キナーゼM2 (PKM2) は,腫瘍におけるワルバーグ効果を誘発する.
- PKM2はまた,非代謝機能を通じて遺伝子転写を調節する.
- PKM2の転写調節の正確なメカニズムは完全に理解されていません.
研究 の 目的:
- PKM2が遺伝子転写を調節する非代謝的メカニズムを解明する.
- ヒストンの改変におけるPKM2の役割とその腫瘍形成への影響を調査する.
主な方法:
- ヒストンH3へのPKM2結合が研究されている.
- ヒストンH3をT11でリン酸化し,K9でアセチル化することを分析した.
- HDAC3の標的遺伝子プロモーターからの解離を評価した.
- サイクリンD1およびc-Myc発現に対する影響を評価した.
- PKM2発現,グリオマのグレード,および予後と相関するヒストン変化レベル.
主要な成果:
- PKM2は,EGF受容体の活性化時に,ヒストンH3をT11で直接結合し,リン酸化する.
- このリン酸化は,CCND1およびMYCプロモーターからのHDAC3解離を促進します.
- PKM2依存ヒストンの改変は,EGF誘発のサイクリンD1とc-Mycの発現を促進する.
- これらのエピジェネティックの変化は,腫瘍細胞の増殖,細胞サイクル進行,脳腫瘍発生に不可欠です.
- ヒストンH3 T11のリン酸化レベルは,核PKM2,グリオマのグレード,および患者の予後と相関しています.
結論:
- PKM2は非代謝的な役割においてタンパク質キナーゼとして機能し,ヒストンH3.3を改変する.
- PKM2媒介ヒストンの改変は,表遺伝的遺伝子調節と腫瘍発生に不可欠である.
- ヒストンH3 T11のリン酸化は,グリオマの悪性および予後のための潜在的なバイオマーカーとして機能します.
関連する概念動画
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Histone Modification
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Phosphorylation
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...


